IL2 and rheumatoid arthritis: NK CD56brightCD16− NK cells have been found in vivo at increased proportions during IL-2 therapy [31], in affected tissues by pathological inflammatory conditions like rheumatoid arthritis [32] and ex vivo IL-2-expanded primary NK cells [12].